ArticleScientific reports2025
A key amino acid site associated with rhodopsin mammal evolution to diurnal vision.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Rhodopsin is a photoreceptor protein found in the vertebrate retina used as a landmark for vision evolution studies at the molecular level. Here, we examined the biochemical and functional performance of modern rhodopsin from three different mammal species- bovine, murine and human-to analyze their visual pigment evolutionary relationships. We selected these species for their relevance in vision research, their different position on the phylogenetic tree and their diverse ethology regarding nocturnal (mouse) and diurnal (bovine and human) life. We report on the important role of the amino acid at position 290 as a key player in the active rhodopsin conformation stability. Our spectroscopic analysis shows that the retinal release process for mouse rhodopsin (L290) is significantly slower, meaning a more stable and durable active state, compared to the human and bovine cases (I290). This finding is supported by the faster retinal release rate observed in the L290I mutant mouse rhodopsin, where the nocturnal mutated pigment behaved like diurnal rhodopsin. The result suggests a potential link between the amino acid at this position and the activity pattern (nocturnal or diurnal). This association was also observed when comparing the sequences of 79 mammal species at position 290, and better appreciated in more specialized primate and rodent orders. Moreover, we propose an evolutionary mechanism in rhodopsin specialization for diurnal and nocturnal life, implying a compromise between the prevalence of damage protection under bright light in nocturnal therian mammals (L290) and dark adaptation under dim light in diurnal therian mammals (I290).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.